Edronax
Recall
|
Medicines
|
27/07/2017
The marketing authorization holder has informed its supplied customers in a letter dated July 25, 2017, that a test result within the scope of a stability study showed a reduced active ingredient content. Therefore, the batch 559CG placed on the market in Austria, which is related to this stability study, is recalled from the market.
| Name of the medicinal product | Edronax 4 mg -Tabletten |
|---|---|
| Marketing authorisation number(s) | 1-22230 |
| Marketing authorisation holder | Pfizer Corporation Austria GmbH |
| Batch number(s) | 559CG |
| Classification of the recall | 2 |
| BASG reference number | INS - 640.001 - 2197 |
Further inquiry note
Page last modified:
12/07/2022